Menu
Back to Journals » Integrated Blood Pressure Control » Volume 6 » default
Integrated Blood Pressure Control
ISSN: 1178-7104
- View all (157)
- Volume 16, 2023 (11)
- Volume 15, 2022 (10)
- Volume 14, 2021 (19)
- Volume 13, 2020 (19)
- Volume 12, 2019 (5)
- Volume 11, 2018 (10)
- Volume 10, 2017 (6)
- Volume 9, 2016 (10)
- Volume 8, 2015 (7)
- Volume 7, 2014 (8)
- Volume 6, 2013 (15)
- Volume 5, 2012 (4)
- Volume 4, 2011 (8)
- Volume 3, 2010 (17)
- Volume 2, 2009 (5)
- Volume 1, 2008 (3)
Archive: Volume 6, 2013
Impact of AT2-receptor stimulation on vascular biology, kidney function, and blood pressure
Danyel LA, Schmerler P, Paulis L, Unger T, Steckelings UM
Integrated Blood Pressure Control 2013, 6:153-161
Published Date: 22 November 2013
Management of patients with resistant hypertension: current treatment options
Kumar N, Calhoun DA, Dudenbostel T
Integrated Blood Pressure Control 2013, 6:139-151
Published Date: 22 October 2013
Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine
Funder JW
Integrated Blood Pressure Control 2013, 6:129-138
Published Date: 4 October 2013
Treating resistant hypertension: role of renal denervation
Urban D, Ewen S, Ukena C, Linz D, Böhm M, Mahfoud F
Integrated Blood Pressure Control 2013, 6:119-128
Published Date: 11 September 2013
Prevalence of hypertension and its risk factors in southwest Ethiopia: a hospital-based cross-sectional survey
Gudina EK, Michael Y, Assegid S
Integrated Blood Pressure Control 2013, 6:111-117
Published Date: 31 July 2013
Current perspectives on treatment of hypertensive patients with chronic obstructive pulmonary disease
Chandy D, Aronow WS, Banach M
Integrated Blood Pressure Control 2013, 6:101-109
Published Date: 9 July 2013
The TRINITY Study: distribution of systolic blood pressure reductions
Sugimoto DH, Chrysant SG, Melino M, Lee J, Fernandez V, Heyrman R
Integrated Blood Pressure Control 2013, 6:89-99
Published Date: 12 July 2013
A review of the gastrointestinal therapeutic system (GITS) formulation and its effectiveness in the delivery of antihypertensive drug treatment (focus on nifedipine GITS)
Meredith PA, Elliott HL
Integrated Blood Pressure Control 2013, 6:79-87
Published Date: 25 June 2013
Current perspectives on combination therapy in the management of hypertension
Mallat SG, Itani HS, Tanios BY
Integrated Blood Pressure Control 2013, 6:69-78
Published Date: 17 June 2013
Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination
Hovater MB, Jaimes EA
Integrated Blood Pressure Control 2013, 6:59-67
Published Date: 14 June 2013
Long-acting nifedipine for hypertensive patients in the Middle East and Morocco: observations on efficacy and tolerability of monotherapy or combination therapy
Ghoneim RA, Omar AK, Sebastian VJ, Kassab R, Akijian G, Hafiz M, Schmidt B
Integrated Blood Pressure Control 2013, 6:49-57
Published Date: 5 June 2013
Azilsartan/chlorthalidone combination therapy for blood pressure control
Cheng JW
Integrated Blood Pressure Control 2013, 6:39-48
Published Date: 27 May 2013
Cardio-ankle vascular index (CAVI) as an indicator of arterial stiffness
Sun CK
Integrated Blood Pressure Control 2013, 6:27-38
Published Date: 30 April 2013
Current perspectives on rosuvastatin
Hu M, Tomlinson B
Integrated Blood Pressure Control 2013, 6:15-25
Published Date: 18 April 2013
Efficacy and tolerability of a single-pill combination of telmisartan 80 mg and hydrochlorothiazide 25 mg according to age, gender, race, hypertension severity, and previous antihypertensive use: planned analyses of a randomized trial
Zhu D, Bays H, Gao P, Mattheus M, Voelker B, Ruilope LM
Integrated Blood Pressure Control 2013, 6:1-14
Published Date: 3 April 2013